Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen.
about
Treatment of acute periprosthetic infections with prosthesis retention: Review of current conceptsImplant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip ArthroplastyBiofilms in periprosthetic orthopedic infectionsSerum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty.Clinical practice. Infection associated with prosthetic joints.Oral antibiotics are effective for highly resistant hip arthroplasty infections.Evaluation of antimicrobial effects of novel implant materials by testing the prevention of biofilm formation using a simple small scale medium-throughput growth inhibition assay.Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.Body mass characteristics of hip osteoarthritis patients experiencing aseptic loosening, periprosthetic fractures, dislocation, and infections after total hip replacement.Total hip replacement infected with Mycobacterium tuberculosis complicated by Addison disease and psoas muscle abscess: a case report.Meta-analysis shows that obesity may be a significant risk factor for prosthetic joint infections.Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years.Prosthetic joint infections.Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapyObesity is a major risk factor for prosthetic infection after primary hip arthroplasty.Clinical Implication of Diabetes Mellitus in Primary Total Hip ArthroplastyEfficacy of Debridement for Early Periprosthetic Joint Infection after Hip Arthroplasty.Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients.One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcomeAggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements.Rifampin combination therapy for nonmycobacterial infections.Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review.Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?First report of prosthetic joint infection by Gemella sanguinis and associated "pseudosatelliting" phenomenon on cultureAn update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Arthroplasty-center related retrospective analysis of risk factors for Periprosthetic Joint Infection after primary and after revision Total Hip Arthroplasty.Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.[Treatment of periprosthetic infections].The diagnosis of periprosthetic infection.Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study.Use of Common Inflammatory Markers in the Long-Term Screening of Total Hip Arthroprosthesis Infections: Our Experience.Significance of sentinel infective events in haematogenous prosthetic knee infections.Antimicrobial photodynamic therapy-a promising treatment for prosthetic joint infections.Managing an Acute and Chronic Periprosthetic Infection.Self-Resolution of a Draining Sinus Tract in a Patient with Chronic Periprosthetic Hip Infection.Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.Sonication: a valuable technique for diagnosis and treatment of periprosthetic joint infections.Treatment recommendations and strategies for the management of bone and joint infections
P2860
Q27022797-072F9EB3-A1F6-4A6D-A31F-A11A45A377B4Q28071834-AEFB5BF6-7773-4DC4-9E62-BE4CA511590AQ28082491-3D83A633-8AE4-415D-AFDC-51B0361716CCQ28392406-659BF0D8-E20A-499C-9F0D-421E3BBBFF20Q33634769-642CBAE9-9BFA-4504-AD1D-F43E5E72D09DQ33771840-455D647A-0892-4213-925E-F8BC53A5E716Q33838767-2DA807D4-32E8-44B6-A0CC-3CBA2177F51DQ34204672-FE83EC44-EC73-419A-AB1D-0564AF9C6451Q35141244-2FD06830-B036-411E-88FD-55EFCE14B773Q35205467-B49BCD81-5E8F-43D8-9BFD-09646C8DB395Q35695059-57663BB2-8DBB-4913-98BD-70E16EBA15ADQ35745609-63C27DF0-2317-469E-A077-BBB170266C8DQ36013589-F43FFA8C-1AB4-4F25-9E8A-A7E4FE486B4EQ36206844-DA884943-310E-4CDA-89CB-1FA2D0ECAA17Q36505327-F1710F1B-1E31-415D-BCBD-EFA83D0068BDQ36826434-A4202536-3EE5-4D3D-B51D-ABD81647CC9CQ37147136-8CCEACD5-93BD-4DAC-A8A3-73FC5DCAA10BQ37147665-97A1B961-8DA5-49A6-BE8F-BC01E71D7CB8Q37158397-180D917C-7B3F-40D7-B499-6BEDE9267D4EQ37187474-7CA08168-5F91-4FC5-88D8-37D1A566FC8BQ37570739-2C67364C-6C2F-4940-B444-38A4440D4229Q37672039-B3DBE94B-3A40-4751-AF13-6554D13FE714Q37973405-CC5EBB2B-CB50-4E03-8FD4-10DFA11FB6FFQ38230862-45B926B0-4881-4B00-A874-EF9897923F94Q38285086-EE770242-AD00-4FB5-AEFD-6AD5BF4D99E5Q38314400-EFB474DD-FFED-4C06-A2B4-515EA44B1D21Q38877350-7116886D-D214-4545-B707-E73DB7C6C993Q39200930-76F48D0F-6166-4D31-99C3-9E92FAD91F10Q40590767-26B9CEB7-4EE0-46F1-A188-ECA5BCAE02D0Q42253222-B6C174F0-5D74-4E8D-A66F-9B1D1F7E8F63Q42325197-2F4E6463-88AE-4AB2-91F2-4C485EF6B2FEQ43375821-D2D651FF-0C8B-48FB-89A9-7A01A2C7796EQ45013508-57BF3910-3040-4733-8EBB-FB05232FC21FQ46238509-0096E6CA-08C5-471E-873C-FD230415896CQ47551517-E4E797A9-F4E6-4D67-902A-2335EAD44EB3Q52579011-74CFC512-EE9E-45F3-ADA1-6727D1B724B7Q55351954-1F8C0A11-9716-4E56-8FC4-91140CEDC16CQ55641942-99D32A2A-B66E-44A2-A067-19ABEFCE8225Q58405400-85EED392-CFC6-4F4D-9C30-919C3F38B2F4
P2860
Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Risk factors associated with a ...... with a rifampinbased regimen.
@en
Risk factors associated with a ...... with a rifampinbased regimen.
@nl
type
label
Risk factors associated with a ...... with a rifampinbased regimen.
@en
Risk factors associated with a ...... with a rifampinbased regimen.
@nl
prefLabel
Risk factors associated with a ...... with a rifampinbased regimen.
@en
Risk factors associated with a ...... with a rifampinbased regimen.
@nl
P2093
P50
P1433
P1476
Risk factors associated with a ...... t with a rifampinbased regimen
@en
P2093
Derek Carr
John Daffy
Peter Stanley
P304
P356
10.1080/17453670710014527
P577
2007-12-01T00:00:00Z